Lapinig, Anthony T.
HRN: 22 07 81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/14/2022
11/21/2022
IV
4.5
Q6h
Pelvic Abscess
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes